Antimicrobial resistance in New Zealand: the evidence and a call for action
Humphrey W Pullon, John Gommans, Mark G Thomas, Sarah Metcalf, Rebecca Grainger, Harriet Wild
Microorganisms (eg bacteria) are developing resistance to a range of antimicrobial drugs, including antibiotics: this is known as antimicrobial resistance (AMR). Standard treatments are now becoming ineffective, which increases the risk of adverse outcomes (including death) and the spread of the infection. AMR is increasing globally where poor sanitation, close contact between humans and animals and unregulated prescribing are common. In New Zealand, there is increasing resistance in infections caused by Staphylococcus aureus, Enterobacteriaceae (eg E. Coli) and Neisseria gonorrhoeae. These bacteria are common causes of infection, and may occur in hospital and community settings. New Zealand must prioritise a plan to prevent increasing AMR, which includes prescribing guidelines, antimicrobial stewardship programmes to promote optimal use of antibiotics and public health campaigns.